Great news in the update. Domrex pharma to distribute in Canada, 5m at least expected in first three years under this agreement, which is on top of existing North America agreement with Cardinal. Revenue from new deal to start within 3 months.
Also advanced negotiations with ditributors from other regions and decisions on supply tenders expected this quarter.
No shares available and low market cap, will be interesting to see the quarterly.
I think this is my only share (apart from NMS) that has been rising lately!!
ICU Price at posting:
0.0¢ Sentiment: LT Buy Disclosure: Held
